IMC Chicago’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Sell
138,100
-9,500
-6% -$14.4K ﹤0.01% 5621
2026
Q1
$267K Sell
147,600
-88,000
-37% -$152K ﹤0.01% 4726
2025
Q4
$318K Buy
+235,600
New +$335K ﹤0.01% 3766
2022
Q2
– Sell
-86,500
Closed -$285K – 1119
2022
Q1
$285K Sell
86,500
-156,300
-64% -$549K ﹤0.01% 1055
2021
Q4
$1.1M Buy
+242,800
New +$1.83M ﹤0.01% 955

Other funds holding OCGN

IMC Chicago's OCGN Position: Q2 2026 in Review

IMC Chicago sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 11,569 shares — an estimated $17.6K sold.

IMC Chicago first reported a position in OCGN in Q1 2026 and held it in 1 quarter. The position peaked at $20.9K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • IMC Chicago reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 11,569 Ocugen shares in Q2 2026, an estimated $17.6K.
  • IMC Chicago first reported a position in Ocugen in Q1 2026 and held it in 1 quarter.
  • IMC Chicago's Ocugen position peaked at $20.9K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.